XO1

XO1

XO1

Biotech company developing ichorcumab, an anti-thrombin antibody that delivers anticoagulation without bleeding
Founded
2013
Raised
$11M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$11,000,000
Venture capital (Series A) - 2013
Team Size
1–10
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when XO1 makes some noise.